Home・Stock List・Erasca Inc

Erasca Inc

Closed

14.21 -1.93

Buy Sell

Overview

Share price change

24h

Current

Min

14.2

Max

14.85

Key metrics
By Trading Economics
Income	139M -44M
EPS	-0.14
Employees	103
EBITDA	139M -43M

Recommendations
By TipRanks
Recommendations	Strong Buy
12 Months Forecast	+66.15% upside

Dividends
By Acuity
Next Earnings	10 Nov 2026

Market Stats
By TradingEconomics
Market Cap	-1B 5.3B
Previous open	16.14
Previous close	14.21

Erasca Inc Chart

Past performance is not a reliable indicator of future results.

Related News

25 Sept 2026, 23:56 UTC

Rocket Pharmaceuticals Inc is advancing in after-market trading, gaining significantly since Friday's close after a recent decline over the past month.

25 Sept 2026, 23:55 UTC

AtriCure Inc is trading modestly higher in after-market hours, remaining above its 20-day moving average despite retracing some initial gains.

25 Sept 2026, 23:55 UTC

Wendy's Co saw modest gains during after-market hours on Friday, continuing its upward movement but remaining below its 20-day moving average.

25 Sept 2026, 23:55 UTC

Lexicon Pharmaceuticals Inc is rising in after-market trading, gaining ground since Friday's close, marking a notable divergence from four consecutive sessions of losses.

25 Sept 2026, 23:55 UTC

Cognizant Technology Solutions Corp is trading modestly higher in after-market hours, reaching a peak return since Friday's close, despite remaining below its 20-day moving average.

25 Sept 2026, 23:51 UTC

Hamilton Beach Brands Holding Co has advanced in after-market trading, significantly above its 20-day moving average and near the upper end of its one-month range.

25 Sept 2026, 23:51 UTC

Social Media

Darden Restaurants Inc reported a rise in sales to $3.2 billion, but net income fell, leading to a decline in stock price in after-market trading.

25 Sept 2026, 23:51 UTC

News

CDW Corp completed its acquisition of Lovelytics, enhancing its Services and Solutions portfolio, as shares advanced in after-market trading.

25 Sept 2026, 23:51 UTC

Krispy Kreme Inc is advancing in after-market trading, showing a notable increase since Friday's close, despite being below its 20-day moving average.

25 Sept 2026, 23:51 UTC

Pacific Biosciences of California Inc is trading lower in after-market hours, reflecting a notable decline since Friday's close and today's sharp loss.

25 Sept 2026, 23:51 UTC

News

AbbVie Inc received FDA approval for Juvmo (Tavapadon), a Parkinson's treatment, contributing to a modest rise in shares during after-market trading.

25 Sept 2026, 23:51 UTC

Southern Co is trading slightly higher in after-market hours, though its price remains below the 20-day moving average after four consecutive lower closes.

25 Sept 2026, 23:51 UTC

Brazil's Industrial Production MoM data release on October 2, 2026, expected to reflect cautious market sentiment amid agricultural sector challenges and external economic pressures.

25 Sept 2026, 23:51 UTC

S&P/Case-Shiller Index Forecasts 2.2% Year-over-Year Home Price Increase Amid Mixed Housing Sentiment and Rising Treasury Yields

25 Sept 2026, 23:51 UTC

South Korea's S&P Global Manufacturing PMI set for October 1 release amid slowing growth and geopolitical tensions impacting market sentiment.

25 Sept 2026, 23:50 UTC

Southern Missouri Bancorp Inc is trading modestly lower in after-market hours, positioned below its 20-day moving average and near the lower end of its one-month range.

25 Sept 2026, 23:50 UTC

Upstart Holdings Inc is trading modestly higher in after-market hours, remaining significantly below its 20-day moving average and near the lower end of its one-month range.

25 Sept 2026, 23:50 UTC

ABM Industries Inc is down in after-market trading, moving from a slight dip to a more pronounced decline since Friday's close.

25 Sept 2026, 23:50 UTC

Arcus Biosciences Inc is trading lower in after-hours, reaching its lowest point of the day and remaining well below its 20-day moving average.

25 Sept 2026, 23:50 UTC

Ambarella Inc is rising in after-market trading, continuing its positive trend and remaining significantly above its 20-day moving average.

25 Sept 2026, 23:50 UTC

Recursion Pharmaceuticals Inc has advanced in after-market trading, remaining above its 20-day moving average and near the upper end of its one-month trading range.

25 Sept 2026, 23:50 UTC

Etsy Inc. has advanced in after-market trading, despite a notable decline from its earlier high and positioning below its 20-day moving average.

25 Sept 2026, 23:50 UTC

Baker Hughes Co is trading modestly higher in after-market hours, showing unusual upward movement despite remaining below its 20-day moving average.

25 Sept 2026, 23:50 UTC

Altria Group Inc is experiencing a slight increase in after-market trading, advancing since Friday's close despite some unusual activity and price retracement.

25 Sept 2026, 23:50 UTC

Medtronic PLC is down in after-market trading, continuing a seven-session trend of lower finishes and remaining significantly below its 20-day moving average.

25 Sept 2026, 23:50 UTC

Tencent Music Entertainment Group declined in after-market trading, continuing a downward trend since Friday's close, despite remaining above its 20-day moving average.

25 Sept 2026, 23:46 UTC

Parker-Hannifin Corp is trading modestly higher in after-market hours, remaining above its 20-day moving average and near the upper end of its one-month range.

25 Sept 2026, 23:46 UTC

Northern Oil and Gas Inc is trading modestly higher in after-market hours, reaching a peak return since Friday's close, though still below its 20-day moving average.

25 Sept 2026, 23:46 UTC

Modest increase in after-market trading, peak return near 0.9%.

25 Sept 2026, 23:46 UTC

Correlated Moves

Alaska Air Group Inc's shares are trading roughly flat in after-market hours, reflecting routine activity amid slight gains in the Fidelity Enhanced Small Cap Core ETF.

Peer Comparison

Price change

Erasca Inc Forecast

Price Target

By TipRanks

66.15% upside

12 Months Forecast

Average 24.125 USD 66.15%

High 33 USD

Low 20 USD

Based on 8 Wall Street analysts offering 12 month price targets forErasca Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

8 ratings

Buy

Hold

Sell

Based on 8 analysts giving stock ratings to Erasca Inc - Dist in the past 3 months.

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Erasca Inc

Erasca, Inc., a clinical-stage precision oncology company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's lead product is naporafenib which is in phase 1b trial for patients with RAS Q16X solid tumors and plans to initiate a pivotal Phase 3 trial for patients with NRASm melanoma. It also develops ERAS-007, an oral inhibitor of ERK1/2 for the treatment of non-small cell lung and colorectal cancer, and advanced gastrointestinal malignancies; and ERAS-601, an oral SHP2 inhibitor for patients with advanced or metastatic solid tumors. In addition, it is developing ERAS-801, a central nervous system-penetrant EGFR inhibitor which is in phase 1 clinical trials for the treatment of patients with recurrent glioblastoma multiforme. The company entered into license agreement with Novartis to develop, manufacture, use, and commercialize naporafenib; Katmai Pharmaceuticals, Inc. to develop, manufacture, use, and commercialize ERAS-801 and certain other related compounds; and NiKang Therapeutics, Inc. to develop and commercialize ERAS-601 and certain other related compounds. Erasca, Inc. was incorporated in 2018 and is headquartered in San Diego, California.